Table 2.
Patient demographics and baseline characteristics.
| Variables | RIT (n=40) | CIT (n=81) | t/x2 value | p value |
|---|---|---|---|---|
| Gender (Male/Female), n/n | 26/14 | 59/22 | 1.791 | 0.181 |
| Age (year) | 9.85 ± 3.37 | 8.4 ± 2.40 | 1.653 | 0.103 |
| Parents’ education degree Bachelor or above△, n(%) |
26 (65.00%) |
56 (69.14%) |
0.753 |
0.382 |
| Family income (RMB) | 0.524 | 0.471 | ||
| ≤25000/month, | 32 (80.00%) | 58 (71.60%) | ||
| >25000/month, | 8 (20.00%) | 23 (28.40%) | ||
| Diagnosis | 6.982 | 0.065 | ||
| AR | 32 (80.00%) | 64 (79.01%) | ||
| AA, | 6 (15.00%) | 6 (7.41%) | ||
| AR and AA | 2 (5.00%) | 11 (13.58%) | ||
| Family history Allergic diseases |
2.215 |
0.142 |
||
| Yes | 12 (30.00%) | 36 (44.44%) | ||
| No | 28 (70.00%) | 45 (55.56%) | ||
| Multiple sensitization✩ | 0.168 | 0.691 | ||
| Yes | 6 (15.00%) | 10 (12.35%) | ||
| No | 34 (85.00%) | 71 (87.65%) | ||
| Clinical assessment | ||||
| VAS score | 5.30 ± 0.97 | 5.37 ± 1.03 | 0.345 | 0.729 |
| CSMS score | 3.24 ± 0.53 | 3.32 ± 0.85 | 0.563 | 0.575 |
Continuous variables were expressed as means ± SD while categorical variables were expressed as N (%) unless otherwise indicated.
△at least one parent’ education degree was bachelor or above.
✩patients with other allergens besides allergy to mites.
RIT, rush subcutaneous immunotherapy+1 dose of anti-IgE combination; CIT, conventional allergen immunotherapy; AR, allergic rhinitis;, AA, allergic asthma;, VAS, visual analogue scale; CSMS, comprehensive symptom and medication score.